What is Mykohaug?
Mykohaug lozenges are dissolved slowly in the mouth to prevent and treat thrush. Thrush, also called candidiasis or white mouth, is a fungus infection of the mouth and throat. Mykohaug may also be used for other problems as determined by your doctor.
Mykohaug is available only with your doctor's prescription.
Mykohaug indications
Mykohaug Lozenges are indicated for the local treatment of oropharyngeal candidiasis. The diagnoses should be confirmed by a KOH smear and/or culture prior to treatment.
Mykohaug Lozenges are also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. There are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence.
How should I use Mykohaug?
Use Mykohaug inserts as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- An extra patient leaflet is available with Mykohaug inserts. Talk to your pharmacist if you have questions about this information.
- Mykohaug inserts is for vaginal use only. Do not use it rectally or take by mouth.
- Using the applicator provided, insert 1 suppository high into the vagina at bedtime for 3 days.
- Some forms of this product come with 3 disposable applicators. If this product contains disposable applicators, throw away each applicator after use.
- Some forms of this product come with one applicator to be used for all 3 days of treatment. If this product contains only one applicator, do not throw it away after use. Separate the pieces of the applicator and wash with warm, soapy water immediately after use. Rinse thoroughly. Make sure the applicator is completely dry before the next use.
- Wash your hands immediately after using Mykohaug inserts.
- To clear up your infection completely, use Mykohaug inserts for the full course of treatment. Keep using it even if you feel better in a few days.
- If you miss a dose of Mykohaug inserts, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.
Ask your health care provider any questions you may have about how to use Mykohaug inserts.
Uses of Mykohaug in details
This product is a combination of B vitamins used to treat or prevent vitamin deficiency due to poor diet, certain illnesses, alcoholism, or during pregnancy. Vitamins are important building blocks of the body and help keep you in good health. B vitamins include thiamine, riboflavin, niacin/niacinamide, vitamin B6, vitamin B12, folic acid, and pantothenic acid.
Some brands of B vitamins also contain ingredients such as vitamin C, vitamin E, biotin, or zinc. Consult your doctor or pharmacist if you have questions about the ingredients in your brand.
How to use Bco
Take this medication by mouth, usually once daily or as directed. Follow all directions on the product package. If you are uncertain about any of the information, consult your doctor or pharmacist.
If you are taking a brand that contains vitamin C, take this medication by mouth with a full glass of water (8 ounces/240 milliliters) unless your doctor directs you otherwise.
If you are taking chewable tablets, chew the tablet thoroughly before swallowing.
If you are taking extended-release capsules, swallow them whole. Do not crush or chew extended-release capsules or tablets. Doing so can release all of the drug at once, increasing the risk of side effects. Also, do not split extended-release tablets unless they have a score line and your doctor or pharmacist tells you to do so. Swallow the whole or split tablet without crushing or chewing.
If you are taking a liquid product, use a medication-measuring device to carefully measure the dose. Do not use a household spoon. Some liquid products need to be shaken before each dose. Some products that contain vitamin B12 need to be placed under the tongue and held there before swallowing. Follow label directions carefully to get the most benefit.
Take this medication regularly in order to get the most benefit from it. To help you remember, take it at the same time each day.
Mykohaug description
Mykohaug is used as a topical ointment or cream in the treatment of Tinea infections. Tinea infections are superficial fungal infections caused by three species of fungi collectively known as dermatophytes (Trichophyton, Microsporum and Epidermophyton). Commonly these infections are named for the body part affected, including tinea corporis (general skin), tinea cruris (groin), and tinea pedis (feet). Mykohaug is a halogenated phenolic ether administered topically for dermotaphytic infections. The mechanism of action is unknown, but also presumed to interfere with yeast membrane structure and function.
Mykohaug dosage
Usual Adult Dose for Tinea Corporis
Apply Mykohaug topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 4 weeks, depending on the nature and severity of the infection.
Usual Adult Dose for Tinea Cruris
Apply Mykohaug topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 2 weeks, depending on the nature and severity of the infection.
Usual Adult Dose for Tinea Pedis
Apply Mykohaug topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 4 to 8 weeks, depending on the nature and severity of the infection.
Usual Adult Dose for Cutaneous Candidiasis
Apply Mykohaug topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 2 to 4 weeks, depending on the nature and severity of the infection.
Usual Adult Dose for Tinea Versicolor
Apply Mykohaug topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 2 to 4 weeks, depending on the nature and severity of the infection.
Usual Adult Dose for Vaginal Candidiasis
Regimen 1: 100 mg (one 100 mg vaginal suppository) intravaginally once a day for 7 consecutive days alone or in combination with topical application of 1% Mykohaug cream to affected area two times daily for 7 consecutive days.
Regimen 2: 200 mg (one 200 mg vaginal suppository) intravaginally once a day for 3 consecutive days alone or in combination with topical application of 1% Mykohaug cream to affected area two times daily for 7 consecutive days.
Regimen 3: 500 mg (one 500 mg vaginal suppository) intravaginally once.
Regimen 4: One applicatorful of 1% Mykohaug vaginal cream intravaginally once daily (preferably at bedtime) for 7 consecutive days.
Regimen 5: One applicatorful of 2% Mykohaug vaginal cream intravaginally once daily (preferably at bedtime) for 3 consecutive days.
Studies have shown the three and seven day courses of Mykohaug to be equally effective. Patient compliance may be increased with a three day course. Patients who fail to achieve a cure with a single 500 mg dose should be treated with a 3 or 7 day course of Mykohaug.
Weekly or monthly Mykohaug vaginal suppositories appear to be effective topical regimens for chronic suppressive therapy in female patients with HIV.
Usual Pediatric Dose for Tinea Corporis
> 3 years: Apply Mykohaug topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 4 weeks, depending on the nature and severity of the infection.
Usual Pediatric Dose for Tinea Cruris
> 3 years: Apply Mykohaug topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 2 weeks, depending on the nature and severity of the infection.
Usual Pediatric Dose for Tinea Pedis
> 3 years: Apply Mykohaug topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 4 to 8 weeks, depending on the nature and severity of the infection.
Usual Pediatric Dose for Cutaneous Candidiasis
> 3 years: Apply Mykohaug topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 2 to 4 weeks, depending on the nature and severity of the infection.
Usual Pediatric Dose for Tinea Versicolor
> 3 years: Apply Mykohaug topical in a quantity sufficient to cover the affected area and immediately surrounding skin twice a day for 2 to 4 weeks, depending on the nature and severity of the infection.
Usual Pediatric Dose for Vaginal Candidiasis
> 12 years: Regimen 1: 100 mg (one 100 mg vaginal suppository) intravaginally once a day for 7 consecutive days alone or in combination with topical application of 1% Mykohaug cream to affected area two times daily for 7 consecutive days.
Regimen 2: 200 mg (one 200 mg vaginal suppository) intravaginally once a day for 3 consecutive days alone or in combination with topical application of 1% Mykohaug cream to affected area two times daily for 7 consecutive days.
Regimen 3: 500 mg (one 500 mg vaginal suppository) intravaginally once.
Regimen 4: One applicatorful of 1% Mykohaug vaginal cream intravaginally once daily (preferably at bedtime) for 7 consecutive days.
Studies have shown the three and seven day courses of Mykohaug to be equally effective. Patient compliance may be increased with a three day course. Patients who fail to achieve a cure with a single 500 mg dose should be treated with a 3 or 7 day course of Mykohaug.
Weekly or monthly Mykohaug vaginal suppositories appear to be effective topical regimens for chronic suppressive therapy in female patients with HIV.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dialysis
Data not available
Mykohaug interactions
See also:
What other drugs will affect Mykohaug?
Mykohaug should be used cautiously in patients with hyperthyroidism, hypertension and cardiac arrhythmias. All vasopressors should be used cautiously in patients taking monoamine oxidase (MAO) inhibitors.
Mykohaug should not be administered concomitantly with other sympathomimetic drugs (such as isoproterenol) because of possible additive effects and increased toxicity.
Combined effects may induce serious cardiac arrhythmias. They may be administered alternately when the preceding effect of other such drug has subsided.
Administration of epinephrine to patients receiving cyclopropane or halogenated hydrocarbon general anesthetics such as halothane which sensitize the myocardium, may induce cardiac arrhythmia.. When encountered, such arrhythmias may respond to administration of a beta-adrenergic blocking drug. Mykohaug also should be used cautiously with other drugs (e.g., digitalis, glycosides) that sensitize the myocardium to the actions of sympathomimetic drugs.
Diuretic agents may decrease vascular response to pressor drugs such as epinephrine.
Mykohaug may antagonize the neuron blockade produced by guanethidine resulting in decreased antihypertensive effect and requiring increased dosage of the latter.
Mykohaug side effects
See also:
What are the possible side effects of Mykohaug?
Applies to Mykohaug: lozenge/troche
In addition to its needed effects, some unwanted effects may be caused by Mykohaug (the active ingredient contained in Mykohaug Troche). In the event that any of these side effects do occur, they may require medical attention.
Minor Side Effects
Some of the side effects that can occur with Mykohaug may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:
More common:
Note: Some of the side effects, such as abdominal or stomach cramping or pain or diarrhea, usually occur only when the medicine is swallowed
- Abdominal or stomach cramping or pain
- diarrhea
- itching
- nausea or vomiting
- unpleasant mouth sensations
Mykohaug contraindications
See also:
What is the most important information I should know about Mykohaug?
Possible sensitivity to Mykohaug.
Rosacea, acne, perioral dermatitis, tuberculosis of the skin and varicose ulcers.
Mykohaug is not indicated for ophthalmic use and should be used with caution around the eyes.
Teratogenicity: Corticosteroids have been shown to be teratogenic in animals following dermal application. As these agents are absorbed percutaneously, teratogenicity following topical application cannot be excluded.
Use in pregnancy: Mykohaug should not be used during pregnancy.
Active ingredient matches for Mykohaug:
Clotrimazole in Germany.
| Unit description / dosage (Manufacturer) | Price, USD |
| Cream; Vaginal; Clotrimazole | |
| Tablet; Vaginal; Clotrimazole | |
| Tablets; Vaginal; Clotrimazole | |
List of Mykohaug substitutes (brand and generic names): | |
| Mykofungin 6 Kombipackung | |
| Cream; Vaginal; Clotrimazole / Tablet; Vaginal; Clotrimazole | |
| Mykohaug 3 Kombi (Germany) | |
| Mykohaug C (Germany) | |
| Cream; Vaginal; Clotrimazole | |
| Mykohaug C3 (Germany) | |
| Cream; Vaginal; Clotrimazole | |
| Tablet; Vaginal; Clotrimazole | |
| Tablets; Vaginal; Clotrimazole | |
| Mykosporin | |
| Naderm RF | |
| Naderm RF Skin 5 gm Cream (Abbott Healthcare Pvt Ltd (AHPL)) | $ 0.29 |
| NADERM RF 0.025%/0.5%/1% CREAM 1 tube / 5 GM cream each (Abbott Healthcare Pvt Ltd (AHPL)) | $ 0.25 |
| Naderm-RF (India) | |
| Naderm-RF Beclometasone dipropionate0.025 %, Clotrimazole 1 %, Neomycin sulphate 0.5 %, Chlorocresol 0.1 %. CRM / 5g (AHPL) | $ 0.29 |
| 5g (AHPL) | $ 0.29 |
| NADERM-RF cream 5g (AHPL) | $ 0.29 |
| Nalbix (Portugal) | |
| Nanoderm | |
| Nanoderm Skin 5 gm Ointment (Austro Labs) | $ 0.34 |
| Neo Clotrimazyl (Brazil) | |
| Neo-Zol | |
| Cream; Topical; Clotrimazole 1% (Neolab) | |
| Cream; Vaginal; Clotrimazole 1% (Neolab) | |
| Cream; Vaginal; Clotrimazole 2% (Neolab) | |
| Neo-Zol Cream | |
| Neo-Zol Topical | |
| Neosten (Bangladesh, Myanmar) | |
| Neosten VT (Myanmar) | |
| Nestic (Thailand) | |
| Nestic 100 mg x 6's (Asian pharm) | $ 0.76 |
| Neverfungol (Peru) | |
| Nidason (Vietnam) | |
| Nidason B 1 tube 10 g | |
| Nidason B 1 tube 30 g | |
| Nidason G 1 tube 10 g | |
| Nidason 1 tube 10 g | |
| Nidason 150 mg x 2 Blister x 5 Tablet | |
| Nidason 1 % x 1 tube 10 g | |
| NIFUGAL (India) | |
| NIFUGAL Cream/ Gel/ Ointment / 1/ % / 15gm units (Indon (Zydus Cadila Healthcare Ltd.)) | $ 0.19 |
| Nifugal 1% w/v M-PAINT / 15ml (Indon (Zydus Cadila Healthcare Ltd.)) | $ 0.20 |
| 1 % w/v x 15ml (Indon (Zydus Cadila Healthcare Ltd.)) | $ 0.20 |
| Nifugal Mouth/Throat 15 ml Zydus Mouth Paint (Indon (Zydus Cadila Healthcare Ltd.)) | $ 0.20 |
| Nifugal Mouth/Throat 15 ml Solution (Indon (Zydus Cadila Healthcare Ltd.)) | $ 0.20 |
| NIFUGAL 1% OINTMENT 1 tube / 15 GM ointment each (Indon (Zydus Cadila Healthcare Ltd.)) | $ 0.19 |
| Nifugal 1% w/v M-PAINT / 15ml (Indon (Zydus Cadila Healthcare Ltd.)) | $ 0.20 |
| Nifugal 1% w/w Ointment (Indon (Zydus Cadila Healthcare Ltd.)) | $ 0.01 |
| NIFUGAL MOUTH PAINT (India) | |
| 1 % w/v x 15ml (GSK) | $ 0.20 |
| Nifugal Mouth Paint 1% w/v SOLN / 15ml (GSK) | $ 0.20 |
| NIFUGAL MOUTH PAINT mouth paint 1 % w/v x 15ml (GSK) | $ 0.20 |
| Nifugal Mouth Paint 1% w/v SOLN / 15ml (GSK) | $ 0.20 |
See 2936 substitutes for Mykohaug | |
References
- DailyMed. "BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubChem. "clotrimazole". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "clotrimazole". http://www.drugbank.ca/drugs/DB00257 (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Mykohaug are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Mykohaug. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
